Page last updated: 2024-11-05

troglitazone and Starvation

troglitazone has been researched along with Starvation in 2 studies

Troglitazone: A chroman and thiazolidinedione derivative that acts as a PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) agonist. It was formerly used in the treatment of TYPE 2 DIABETES MELLITUS, but has been withdrawn due to hepatotoxicity.

Starvation: Lengthy and continuous deprivation of food. (Stedman, 25th ed)

Research Excerpts

ExcerptRelevanceReference
"Among three gastric cancer cell lines, MKN28, MKN45, and MKN74, only the most poorly differentiated MKN45 cells survived >36 h."1.31Remarkable tolerance of tumor cells to nutrient deprivation: possible new biochemical target for cancer therapy. ( Esumi, H; Izuishi, K; Kato, K; Kinoshita, T; Ogura, T, 2000)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fulgencio, JP1
Kohl, C1
Girard, J1
Pégorier, JP1
Izuishi, K1
Kato, K1
Ogura, T1
Kinoshita, T1
Esumi, H1

Other Studies

2 other studies available for troglitazone and Starvation

ArticleYear
Troglitazone inhibits fatty acid oxidation and esterification, and gluconeogenesis in isolated hepatocytes from starved rats.
    Diabetes, 1996, Volume: 45, Issue:11

    Topics: Animals; Caprylates; Carnitine O-Palmitoyltransferase; Cells, Cultured; Chromans; Coenzyme A Ligases

1996
Remarkable tolerance of tumor cells to nutrient deprivation: possible new biochemical target for cancer therapy.
    Cancer research, 2000, Nov-01, Volume: 60, Issue:21

    Topics: Antineoplastic Agents; Cell Survival; Chromans; Chromones; Culture Media, Serum-Free; Enzyme Activat

2000